![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909641/0/en/Outlook-Therapeutics-Announces-UK-MHRA-Marketing-Authorization-of-LYTENAVA-bevacizumab-gamma-for-the-Treatment-of-Wet-AMD.html
https://www.globenewswire.com/news-release/2024/06/11/2896897/0/en/Outlook-Therapeutics-to-Present-at-the-Virtual-Investor-Pitch-Conference.html
https://www.globenewswire.com/news-release/2024/05/28/2889004/0/en/Outlook-Therapeutics-Receives-European-Commission-Marketing-Authorization-for-LYTENAVA-bevacizumab-gamma-for-the-Treatment-of-Wet-AMD.html
https://www.globenewswire.com/news-release/2024/05/15/2882970/0/en/Outlook-Therapeutics-Reports-Financial-Results-for-Second-Quarter-Fiscal-Year-2024-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/13/2880469/0/en/Outlook-Therapeutics-Announces-UK-Submission-of-Marketing-Authorization-Application-MAA-for-ONS-5010-as-a-Treatment-for-Wet-AMD.html
https://www.globenewswire.com/news-release/2024/05/09/2878785/0/en/Outlook-Therapeutics-to-Report-Financial-Results-for-Second-Quarter-Fiscal-Year-2024-on-May-16-2024-and-Host-Inaugural-Quarterly-Conference-Call-and-Webcast.html
https://www.globenewswire.com/news-release/2024/05/02/2874296/0/en/Outlook-Therapeutics-to-Present-at-the-Retina-World-Congress-2024.html
https://www.globenewswire.com/news-release/2024/04/29/2871288/0/en/Outlook-Therapeutics-to-Present-at-the-Ophthalmology-Innovation-Summit-OIS-Retina-Innovation-Showcase.html
https://www.globenewswire.com/news-release/2024/04/15/2863165/0/en/Outlook-Therapeutics-Announces-Closing-of-Private-Placement-of-5-0-Million.html
https://www.globenewswire.com/news-release/2024/03/22/2850893/0/en/Outlook-Therapeutics-Receives-European-Union-Positive-CHMP-Opinion-for-ONS-5010-as-a-Treatment-for-Wet-AMD.html